Compliance to Medicines Working Group Report to PBAC
24 September 2010
The Report of the Compliance to Medicines Working Group is now available for public consultation.
The Report of the Compliance to Medicines Working Group is now available for public
consultation. All interested stakeholders are invited to submit written comments by
31 October 2010.
The Compliance to Medicines Working Group (CMWG) was established at the request of the Pharmaceutical Benefits Advisory Committee (PBAC) in December 2008. The PBAC requested that the working group gather information from experts and published literature on methods for evaluating and interpreting evidence used to support claims that combination products improve consumer compliance and health outcomes. The PBAC also sought guidance on the factors that influence consumer compliance with PBS medicines. An understanding of why consumers are not fully compliant with their drug regimens is important for achieving optimal clinical outcomes, reducing community burden of disease and ensuring the most cost effective use of health resources. The CMWG had 14 members, including representatives of the pharmaceutical industry, researchers, clinicians, consumers, DUSC and PBAC. Members are listed in Appendix 1 of the Report.
A Consumer Fact Sheet on the Compliance to Medicines Working Group Report is also available.
Please forward comments to:
Pharmaceutical Evaluation Section
GPO Box 9848
Canberra ACT 2601